1. Home
  2. MNOV vs CODA Comparison

MNOV vs CODA Comparison

Compare MNOV & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNOV
  • CODA
  • Stock Information
  • Founded
  • MNOV 2000
  • CODA 1994
  • Country
  • MNOV United States
  • CODA United States
  • Employees
  • MNOV N/A
  • CODA N/A
  • Industry
  • MNOV Biotechnology: Pharmaceutical Preparations
  • CODA Industrial Machinery/Components
  • Sector
  • MNOV Health Care
  • CODA Industrials
  • Exchange
  • MNOV Nasdaq
  • CODA Nasdaq
  • Market Cap
  • MNOV 68.2M
  • CODA 88.7M
  • IPO Year
  • MNOV 2005
  • CODA N/A
  • Fundamental
  • Price
  • MNOV $1.26
  • CODA $8.22
  • Analyst Decision
  • MNOV Strong Buy
  • CODA Strong Buy
  • Analyst Count
  • MNOV 2
  • CODA 1
  • Target Price
  • MNOV $7.00
  • CODA $11.00
  • AVG Volume (30 Days)
  • MNOV 15.0K
  • CODA 56.4K
  • Earning Date
  • MNOV 08-07-2025
  • CODA 06-16-2025
  • Dividend Yield
  • MNOV N/A
  • CODA N/A
  • EPS Growth
  • MNOV N/A
  • CODA 21.86
  • EPS
  • MNOV N/A
  • CODA 0.30
  • Revenue
  • MNOV N/A
  • CODA $22,758,966.00
  • Revenue This Year
  • MNOV N/A
  • CODA $11.64
  • Revenue Next Year
  • MNOV N/A
  • CODA $14.53
  • P/E Ratio
  • MNOV N/A
  • CODA $26.63
  • Revenue Growth
  • MNOV N/A
  • CODA 24.78
  • 52 Week Low
  • MNOV $1.12
  • CODA $5.76
  • 52 Week High
  • MNOV $2.55
  • CODA $9.89
  • Technical
  • Relative Strength Index (RSI)
  • MNOV 38.94
  • CODA 57.53
  • Support Level
  • MNOV $1.32
  • CODA $7.78
  • Resistance Level
  • MNOV $1.38
  • CODA $8.56
  • Average True Range (ATR)
  • MNOV 0.05
  • CODA 0.45
  • MACD
  • MNOV -0.00
  • CODA 0.00
  • Stochastic Oscillator
  • MNOV 7.69
  • CODA 56.09

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

About CODA Coda Octopus Group Inc. Common stock

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.

Share on Social Networks: